Risedronate Sodium
Product Images NDC 0115-1426

3 FDA label images from Impax Generics · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Risedronate Sodium (NDC 0115-1426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Impax Generics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Risedronate Sodium Delayed Release Tablets 1)

Chemical Structure (Risedronate Sodium Delayed Release Tablets 1)
Chemical structure of Risedronate Sodium with 2.5 molecules of water (hydrate form). The diagram shows the detailed molecular structure including phosphonate groups and a pyridine ring.*
FDA Label Image

Figure 1 (Risedronate Sodium Delayed Release Tablets 2)

Figure 1 (Risedronate Sodium Delayed Release Tablets 2)
A bar chart titled 'Nonvertebral Osteoporosis-Related Fractures Cumulative Incidence Over 3 Years Combined VERT MN and VERT NA' showing the percentage of patients with fractures at various sites (All, Wrist, Humerus, Hip, Pelvis, Leg, Clavicle) comparing placebo and ACTONEL 5 mg groups. The y-axis represents the percentage of patients, with higher incidence in the placebo group across most fracture sites.*
FDA Label Image

Carton (Risedronate Sodium Delayed Release Tablets 3)

Carton (Risedronate Sodium Delayed Release Tablets 3)
Packaging label for Risedronate Sodium Delayed-Release Tablets 35 mg by Impax Generics. The label includes usage instructions, dosage frequency (once a week, 4 tablets), and a reminder to dispense an enclosed Medication Guide. The label also provides storage and safety information and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.